DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dutasteride And Tamsulosin Hydrochloride, and what generic alternatives are available?
Dutasteride And Tamsulosin Hydrochloride is a drug marketed by Actavis Labs Fl Inc, Aurobindo Pharma, Endo Operations, and Zydus Pharms. and is included in four NDAs.
The generic ingredient in DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE is dutasteride; tamsulosin hydrochloride. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dutasteride; tamsulosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dutasteride And Tamsulosin Hydrochloride
A generic version of DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE was approved as dutasteride; tamsulosin hydrochloride by ENDO OPERATIONS on February 26th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE?
- What are the global sales for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE?
- What is Average Wholesale Price for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE?
Summary for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 5 |
Clinical Trials: | 21 |
DailyMed Link: | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Beth Israel Deaconess Medical Center | N/A |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
Ministry of Health, France | Phase 3 |
See all DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE clinical trials
Pharmacology for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
Drug Class | 5-alpha Reductase Inhibitor alpha-Adrenergic Blocker |
Mechanism of Action | 5-alpha Reductase Inhibitors Adrenergic alpha-Antagonists |